Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis

Circulation Journal

Volumn 72, Issue 1, 2008, Pages 56-60

  Aoyama, Toru ^a   Ishii, Hideki ^a,c   Toriyama, Takanobu ^a   Takahashi, Hiroshi ^a   Kasuga, Hirotake ^b   Murakami, Ryuichiro ^c   Amano, Tetsuya ^c   Uetani, Tadayuki ^c   Yasuda, Yoshinari ^c   Yuzawa, Yukio ^c   Maruyama, Shoichi ^c   Matsuo, Seiichi ^c   Matsubara, Tatsuaki ^d   Murohara, Toyoaki ^c  

^a NAGOYA KYORITSU HOSPITAL   (Japan)

^b Department of Nephrology Kyoritsu Hospital   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Hemodialysis; Percutaneous coronary intervention; Sirolimus eluting stents

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; ISCHEMIC HEART DISEASE; JAPANESE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; STATISTICAL SIGNIFICANCE; CALCINOSIS; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; EVALUATION; JAPAN; MIDDLE AGED; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; RESTENOSIS; STANDARD; STENT;

AGED; CALCINOSIS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERLIPIDEMIAS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECURRENCE; RENAL DIALYSIS; SIROLIMUS; STENTS;

EID: 39849084996     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.56     Document Type: Article

References (36)

1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
2. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615.
3. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. The Hemodialysis (HEMO) Study: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362.
4. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003; 92: 1160-1164.
5. Hase H, Nakamura M, Joki N, Tsunoda T, Nakamura R, Saijyo T, et al. Independent predictors of restenosis after percutaneous coronary revascularization in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 2372-2377.
6. Hase H, Joki N, Nakamura M, Tsunoda T, Tanaka Y, Fukazawa M, et al. Favourable long-term outcome by repeated percutaneous coronary revascularization in diabetic haemodialysis patients. Nephrol Dial Transplant 2002; 17: 100-105.
7. Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994; 128: 293-296.
8. Reusser LM, Osborn LA, White HJ, Sexson R, Crawford MH. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 1994; 73: 965-967.
9. Le Feuvre C, Dambrin G, Helft G, Beygui F, Touam M, Grünfeld JP, et al. Clinical outcome following coronary angioplasty in dialysis patients: A case-control study in the era of coronary stenting. Heart 2001; 85: 556-560.
10. Hemmelgarn BR, Ghali WA, Quan H, Brant R, Norris CM, Taub KJ, et al. Poor long-term survival after coronary angioplasty in patients with renal insufficiency. Am J Kidney Dis 2001; 37: 64-72.
11. Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al; RAVEL Study Group. A randomized comparison of a sirolimus-eluting stents versus standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
12. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
13. Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109: 634-640.
14. Nakazawa G, Tanabe K, Aoki J, Onuma Y, Yamamoto H, Higashikuni Y, et al. Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ. J 2006; 70: 1367-1371.
15. Suzuki S, Kamihata H, Hata T, Hayashi F, Miura A, Yoshinaga M, et al. Success rate of implantation and mid-term outcomes of the sirolimus-eluting stent. Circ J 2007; 71: 15-19.
16. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IMF, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-195.
17. Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 2005; 111: 2326-2326.
18. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, et al; DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-2183.
19. Schampaert E, Cohen EA, Schlüter M, Reeves F, Traboulsi M, Title LM, et al; C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115.
20. Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 2005; 26: 1056-1062.
21. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience. Circulation 2006; 113: 2542-2547.
22. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl 2000; 76: S140-S147.
23. Le Feuvre C. Angioplasty and stenting in patients with renal disease. Heart 2000; 83: 7-8.
24. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000; 15: 218-223.
25. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
26. Choi J-H, Kim KL, Huh W, Kim B, Byun J, Suh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic rend failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252.
27. Chen J, Zhang F, Tao Q, Wang X, Zhu J. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolemia. Clin Sci (Lond) 2004; 107: 273-280.
28. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-1457.
29. Gulati R, Jevremovic D, Witt TA, Kleppe LS, Vile RG, Lerman A, et al. Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H512-H517.
30. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 1986; 43: 139-143.
31. Notohamiprodjo M, Andrassy K, Bommer J, Ritz E. Dialysis membranes and coagulation system. Blood Purif 1986; 4: 130-141.
32. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schühlen H, Neumann FJ, et al. Intracoronary stenting and angiographic results: Strut thickness effect on outcome (ISAR-STEREO) trial. Circulation 2001; 103: 2816-2821.
33. Kuchulakanti PK, Torguson R, Chu WW, Canos DA, Rha SW, Clavijo L, et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2006; 97: 792-797.
34. Lemos PA, Arampatzis CA, Hoye A, Daemen J, Ong ATL, Saia F, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005; 95: 167-172.
35. Nakazawa G, Tanabe K, Aoki J, Yamamoto H, Higashikuni Y, Onuma Y, et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-814.
36. Lemos PA, Saia F, Ligthart JMR, Arampatzis CA, Sianos G, Tanabe K, et al. Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108: 257-260.